Half-year results of Sartorius Stedim Biotech

Author's Avatar
Jul 21, 2021

- Sales revenue up 61.1 percent to 1,352 million euros; underlying EBITDA margin 36.1 percent

- Dynamic organic growth; added momentum from pandemic-related business and acquisitions

- Forecast for 2021 raised yet again at the beginning of July

PR Newswire